Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective: Evidence of a relation between use of lipid lowering drugs and cognitive outcomes is mixed. This study aimed to test the association between use of statins and incidence of dementia and cognitive impairment without dementia (CIND) over 5 years of follow-up.
Methods: Data were from a population-based cohort study comprising 1,789 older Mexican Americans. All participants had cognitive and clinical evaluations performed every 12 to 15 months. Participants who fell below specified cutpoints on cognitive tests were then evaluated clinically. Dementia diagnoses were finalized by an adjudication team. A total of 1,674 participants free of dementia/CIND at baseline were included in these analyses. Statin use was verified at each participant's home by medicine cabinet inspection. Cox proportional hazards models were used to evaluate the association between statin use and incidence of dementia/CIND.
Results: Overall, 452 of 1,674 participants (27%) took statins at any time during the study. Over the 5-year follow-up period, 130 participants developed dementia/CIND. In Cox proportional hazards models adjusted for education, smoking status, presence of at least one APOE ε4 allele, and history of stroke or diabetes at baseline, persons who had used statins were about half as likely as those who did not use statins to develop dementia/CIND (HR = 0.52; 95% CI 0.34, 0.80).
Conclusion: Statin users were less likely to have incident dementia/cognitive impairment without dementia during a 5-year follow-up. These results add to the emerging evidence suggesting a protective effect of statin use on cognitive outcomes.
Glossary
- 3MSE=
- Modified Mini-Mental State Examination;
- AD=
- Alzheimer disease;
- ATP=
- Adult Treatment Panel;
- CDC=
- Centers for Disease Control;
- CIND=
- cognitive impairment without dementia;
- DSM-IV=
- Diagnostic and Statistical Manual of Mental Disorders–IV;
- FPG=
- fasting plasma glucose;
- IQCODE=
- Informant Questionnaire on Cognitive Decline in the Elderly;
- LDL-C=
- low density-lipoprotein cholesterol;
- LLT=
- lipid lowering therapy;
- MCI=
- mild cognitive impairment;
- NINCDS-ADRDA=
- National Institute of Neurologic and Communicative Disorders and Stroke–Alzheimer Disease and Related Disorders Association;
- PROSPER=
- Prospective Study of Pravastatin in the Elderly;
- SALSA=
- Sacramento Area Latino Study on Aging;
- SENAS=
- Spanish English Neuropsychological Assessment Scales;
- SEVLT=
- Spanish and English Verbal Learning Test.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
- Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study
- Eddie Vos, www.health-heart.org, 127 Courser Rd, Sutton, Quebec, Canada J0E 2K0vos@health-heart.org
- Herbert H. Nehrlich
Submitted December 14, 2008 - Reply from the authors
- Mary N. Haan, University of Michigan, 109 S. Observatory St, Ann Arbor, MI 48109mnhaan@umich.edu
- C. Cramer, S. Galea, K.M. Langa, J. D. Kalbfleisch
Submitted December 14, 2008 - Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study
- Mark R. Goldstein, MD, Fountain Medical Court, 9410 Fountain Medical Court, Suite A-200, Bonita Springs, FL, 34135markrgoldstein@comcast.net
- Luca Mascitelli, MD, Medical Service, Comando Brigata alpina "Julia", Udine, Italy; Francesca Pezzetta, MD, Cardiology Service, Ospedale di Tolmezzo, Tolmezzo, Italy
Submitted September 11, 2008 - Reply from the authors
- Mary N Haan, University of Michigan, Epidemiology, 109 S Observatory St, rm 5174mnhaan@umich.edu
- Caryn Cramer, Jack Kalbfleisch, Ken Langa, Sandro Galea
Submitted September 11, 2008
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
Emulating a target trial of statin use and risk of dementia using cohort dataEllen C. Caniglia, L. Paloma Rojas-Saunero, Saima Hilal et al.Neurology, August 04, 2020 -
Articles
Association of statin use with cognitive decline in elderly African AmericansS. J. Szwast, H. C. Hendrie, K. A. Lane et al.Neurology, November 05, 2007 -
Views and Reviews
Outcomes after thrombolysis in AIS according to prior statin useA registry and reviewElena Meseguer, Mikael Mazighi, Bertrand Lapergue et al.Neurology, October 22, 2012 -
Articles
Statin therapy is associated with reduced neuropathologic changes of Alzheimer diseaseG. Li, E. B. Larson, J. A. Sonnen et al.Neurology, August 27, 2007